☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Bassil I. Dahiyat
PharmaShots Interview: Xencor's Bassil I. Dahiyat Shares Insight on the US FDA's Approval of COVID-19 Antibody Treatment Leveragin...
August 3, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.